This page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.
Specializing in custom synthesis of carbohydrates, nucleosides, heterocyclics, and APIs for global pharmaceutical R&D. Founded in 2013 in Beijing, we deliver high-purity intermediates with precision and reliability.
Beijing Qinling Meditech Co., Ltd. was founded in 2013 and is located in Yizhuang New City, Beijing. We are dedicated to custom synthesis and custom research, specializing in the production of carbohydrates, nucleosides, and their intermediates for pharmaceutical applications.
Our expertise spans the development of complex organic molecules used in drug discovery and formulation. With a strong focus on quality, scalability, and regulatory compliance, we serve research institutions and pharmaceutical companies worldwide.
Founded
Products
High-purity chemical building blocks for pharmaceutical innovation. Explore our catalog of carbohydrates, nucleosides, heterocyclics, APIs, and specialty intermediates.
CAS: 5336-08-3
A key intermediate in ribose and nucleoside synthesis. Used in antiviral and anticancer drug development.
CAS: Not listed
Glucosamine derivative used in glycosylation reactions and glycoconjugate synthesis.
CAS: 55094-52-5
Protected ribose derivative for nucleoside analog synthesis with high stereocontrol.
CAS: 1309-66-6
Fully protected glucose derivative for complex carbohydrate synthesis.
CAS: 55628-54-1
Glycal donor for stereoselective glycosylation in oligosaccharide assembly.
CAS: 34371-14-7
Intermediate in 2'-deoxynucleoside synthesis, relevant to DNA analogs and antiviral agents.
CAS: 53008-37-2
Protected mannose glycoside used in glycochemistry and vaccine development.
CAS: Not listed
Chiral building block for asymmetric synthesis and pharmaceutical intermediates.
CAS: 3258-07-9
Natural nucleoside analog with potential antiviral and immunomodulatory activity.
CAS: Not listed
Thio-glycoside donor for stable glycosidic bond formation in synthetic glycochemistry.
CAS: Not listed
Sulfur-containing sugar analog with potential as a glycosidase inhibitor.
CAS: Not listed
Protected thioglycoside for controlled glycosylation in complex oligosaccharide synthesis.
Advanced synthesis and analytical expertise to support your drug discovery pipeline.
Tailored synthesis of complex carbohydrates, nucleosides, and heterocyclic compounds to meet specific research needs.
Full characterization using NMR, HPLC, MS, and other advanced techniques to ensure purity and identity.
Seamless transition from milligram to multi-gram or kilogram scale for preclinical and clinical development.
Aug 09, 2020
Jul 15, 2018
Jul 02, 2018
For inquiries, quotes, or collaboration opportunities, visit our official website to contact the QL Meditech team.
Email: [email protected], [email protected]
QQ: 834537306
Phone: +86 010 61241352, +86 189 0132 7973
Fax: +86 010 5885 0721
Address: Rm 401, No.15, Yard 20, Changheng Road, Daxing District, Beijing, 102615, China
Notice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.
For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact [email protected] via your corporate email to cancel. We will cancel your inclusion within 3 business days.
如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系[email protected] 取消收录 我们将在3个工作日取消您的收录
Service Request: If you are other domain and want to be included, please contact [email protected]
如果您是其他域名合作 也请联系[email protected]